Sánchez-Alonzo Kimberly, Belmar Libnny, Parra-Sepúlveda Cristian, Bernasconi Humberto, Campos Víctor L, Smith Carlos T, Sáez Katia, García-Cancino Apolinaria
Laboratory of Bacterial Pathogenicity, Department of Microbiology, Faculty of Biological Sciences, Universidad de Concepción, Concepción 4070386, Chile.
Laboratorio Pasteur, Concepción 4030000, Chile.
Pathogens. 2021 Mar 23;10(3):382. doi: 10.3390/pathogens10030382.
First-line treatment for includes amoxicillin and clarithromycin or metronidazole plus a proton pump inhibitor. Treatment failure is associated with antibiotic resistance and possibly also with internalization of into eukaryotic cells, such as yeasts. Factors triggering the entry of into yeast are poorly understood. Therefore, the aim of this study was to evaluate whether clarithromycin or amoxicillin trigger the entry of into cells.
J99 and ATCC 10231 were co-cultured in the presence of subinhibitory concentrations of amoxicillin and clarithromycin as stressors. Bacterial-bearing yeasts were observed by fresh examination. The viability of bacteria within yeasts was evaluated, confirming the entry of bacteria into , amplifying, by PCR, the gene in total yeast DNA.
Amoxicillin significantly increased the entry of into compared to the control.
the internalization of into in the presence of antibiotics is dependent on the type of antibiotic used, and it suggests that a therapy including amoxicillin may stimulate the entry of the bacterium into , thus negatively affecting the success of the treatment.
[某种细菌]的一线治疗包括阿莫西林和克拉霉素或甲硝唑加质子泵抑制剂。治疗失败与抗生素耐药性有关,也可能与[该细菌]内化进入真核细胞(如酵母)有关。引发[该细菌]进入酵母的因素尚不清楚。因此,本研究的目的是评估克拉霉素或阿莫西林是否会引发[该细菌]进入[酵母]细胞。
将J99和[某种细菌]ATCC 10231在亚抑制浓度的阿莫西林和克拉霉素作为应激源存在的情况下共培养。通过显微镜检查观察携带细菌的酵母。评估酵母内细菌的活力,通过PCR扩增总酵母DNA中的[细菌]基因,确认细菌进入[酵母]。
与对照组相比,阿莫西林显著增加了[该细菌]进入[酵母]的比例。
在抗生素存在的情况下,[该细菌]内化进入[酵母]取决于所用抗生素的类型,这表明包含阿莫西林的治疗可能会刺激细菌进入[酵母],从而对治疗的成功产生负面影响。